Medicare AdvantageFebruary 28, 2019
Clinical criteria updates for specialty pharmacy
Beginning January 1, 2024, Empire became Anthem. This article, published under the former brand, now applies to Anthem.
The following revised clinical criteria will be effective May 1, 2019. Visit www.empireblue.com/pharmacyinformation/clinicalcriteria.html to search for specific clinical criteria. Please share this notice with other members of your practice and office staff.
|
Clinical criteria effective date |
Clinical criteria number |
Clinical criteria |
Clinical criteria (new/revised) |
|
May 1, 2019 |
ING-CC-0001 |
Erythropoiesis Stimulating Agents |
Revised |
|
May 1, 2019 |
ING-CC-0004 |
H.P. Acthar Gel® (repository corticotropin injection) |
Revised |
|
May 1, 2019 |
ING-CC-0072 |
Selective Vascular Endothelial Growth Factor (VEGF) Antagonists |
Revised |
75743MUPENMUB 01/24/2019
PUBLICATIONS: March 2019 Empire Provider Newsletter
To view this article online:
Or scan this QR code with your phone